DAR, MOHAMMED M.,KARAKUNNEL, JOYSON J.,JIANG, HAIYI,KIRKBY, MAXWELL J.
申请号：
CA2983067
公开号：
CA2983067A1
申请日:
2016.04.22
申请国别(地区):
CA
年份:
2016
代理人:
摘要：
The present invention features methods of treating lung cancer (e.g., NSCLC) with an anti-PD-L1 antibody and a tyrosine kinase inhibitor in a subject identified as having an EGFR mutation-positive tumor.
